Dermatologists largely rely on subjective visual examinations of skin lesions such as moles to decide if patients should undergo biopsies to diagnose the disease.

‘The AI system trained using tens of thousands of skin images and their corresponding eumelanin and hemoglobin levels could initially reduce the number of unnecessary biopsies.’

The AI system trained using tens of thousands of skin images and their corresponding eumelanin and hemoglobin levels could initially reduce the number of unnecessary biopsies, a significant health-care cost. It gives doctors objective information on lesion characteristics to help them rule out melanoma before taking more invasive action.




The technology could be available to doctors as early as next year.
"This could be a very powerful tool for skin cancer clinical decision support," said Alexander Wong, a professor of systems design engineering at Waterloo. "The more interpretable information there is, the better the decisions are."
Currently, dermatologists largely rely on subjective visual examinations of skin lesions such as moles to decide if patients should undergo biopsies to diagnose the disease.
The new system deciphers levels of biomarker substances in lesions, adding consistent, quantitative information to assessments currently based on appearance alone. In particular, changes in the concentration and distribution of eumelanin, a chemical that gives skin its colour, and hemoglobin, a protein in red blood cells, are strong indicators of melanoma.
Advertisement
Wong developed the technology in collaboration with Daniel Cho, a former PhD student at Waterloo, David Clausi, a professor of systems design engineering professor at Waterloo, and Farzad Khalvati, an adjunct professor at Waterloo and scientist at Sunnybrook.
Advertisement
Source-Eurekalert